(cat# AS021942, ID s14942) from Fisher-Ambion were used. For transfection U251TMZ cells were grown to 60-80% confluency in DMEM (10% FBS) medium without antibiotics in six-well plates. Cells were transfected with control or specific siRNA to 100 nM in Opti-MEM (Gibco BRL)] using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions and were kept for 72 hours in growth medium before any further experiments.
HR assays using DR-GFP plasmid: U251TMZ cells were stably transfected with pDRGFP (Plasmid 26475, Addgene, USA) and stable Puromycin-resistant cells were selected with 5 μg/mL puromycin (InvivoGen., USA). For homologous recombination (HR) assay, U251TMZ-DRGFP cells were co-transfected with pCBASceI (Plasmid 26477, Addgene) with specified siRNA. Events of GFP expression by HR mediated repair of I-SceI cleaved DRGFP sites were measured by flow cytometry and presented as percent relative the control. GFP flow cytometry 2 | P a g e was performed on live cells by BD FACS caliber and flow data analyzed using CellQuest Software.
Western blotting: Cells were processed for protein extraction and subsequent SDS-poly acrylamide gel electrophoresis as previously described (Gupta et al, 2014) . Proteins (10 µg) were denatured and resolved either on 3-8% Tris-acetate gels (for high molecular weight proteins BRCA1, BRCA2, DNA-PKsc and viculin) or on 4-12% Bis-acrylamide gradient gels (for low molecular weight proteins Rad51, XRCC1, MPG and b-Actin), transferred on to PVDF membrane, blocked in 5% nonfat dry milk and then probed with appropriate primary antibodies diluted in 5% BSA (as listed below) overnight at 4ºC and followed by horseradish peroxidaseconjugated secondary antibodies. Signals were detected by using enhanced chemiluminescence method, and images captured in c300 imager (Azure Biosystems, Dublin, CA).
Primary Antibody
Source and cat # dilution 
Statistics:
In vitro data presented are the mean ± standard error from three or more experiments.
The two-sample t-test was used to make comparisons across groups. Cumulative survival distributions were estimated using the Kaplan-Meier method. The log rank test was used to make comparisons across groups.
